-
Canada Ebola vaccine shipment to Africa stymied by logistics
Canada's experimental Ebola vaccine was stuck in the government lab that developed it as officials puzzled over how to safely transport it, three weeks after it was offered to Africa to fight the deadly epidemic.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
FDA rushes J&J, NewLink Genetics Ebola vaccines to clinical trials
Another Big Pharma player is joining the hustle toward an Ebola vaccine as the death toll surpasses 1,900 victims, eclipsing the total number of people who died from the disease in all previous outbreaks combined.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Nurturing health innovation in Africa: 13 ways to boost research
What needs to happen to reverse the brain drain and secure funding across the continent? Our panel suggest where to start
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
3 Ways The Internet Of Things Is Revolutionizing Health Care
If you or a loved one has undergone medical treatment recently, you’re probably aware of some of the cool new devices that help perform diagnosis and treatment. You may not be aware, however, that some of these devices are connected to the Internet and have become an important part of the Internet of Things (IoT) ecosystem.
- Categories
- Education, Health Care, Telecommunications
-
OPINION: The key to healthcare innovation is empowering nurses
Sandeep Jauhar argued a few months ago in a New York Times’ op-ed that “Nurses Are Not Doctors” and shouldn’t be given the same responsibilities to care for patients.
- Categories
- Health Care
- Tags
- public health
-
WHO officials warn that the epidemic is accelerating rapidly
WHO officials warn that the epidemic is accelerating rapidly
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Chemical test device diagnoses without internet
A handheld device that performs a range of chemical tests and transmits the results for remote analysis through a standard mobile phone call could be commercially available within 12 months.
- Categories
- Health Care, Technology
-
Final trial confirms efficacy of Sanofi’s dengue vaccine
French drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 percent in a large final clinical trial. Sanofi has invested more than 1.3 billion euros ($1.7 billion) in the project, undertaking two decades of research on the world's fastest-growing tropical disease.
- Categories
- Health Care
- Tags
- vaccines
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.